Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

INTRODUCTION: Durvalumab after concurrent chemoradiation (cCRT) is now standard of care for unresected stage III non–small cell lung cancer (NSCLC). However, there is limited data on radiation pneumonitis (RP) with this regimen. Therefore, we assessed RP and evaluated previously validated toxicity m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Shaverdian, Narek, Thor, Maria, Shepherd, Annemarie F., Offin, Michael D., Jackson, Andrew, Wu, Abraham J., Gelblum, Daphna Y., Yorke, Ellen D., Simone, Charles B., Chaft, Jamie E., Hellmann, Matthew D., Gomez, Daniel R., Rimner, Andreas, Deasy, Joseph O.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333832/
https://ncbi.nlm.nih.gov/pubmed/32372571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados